AzTrials
AzTrials

Thyroid NoduleNCT06306599

Human-AI Collaboration for Ultrasound Diagnosis of Thyroid Nodules - a Clinical Trial

A study testing S-Detect for Thyroid in people with Thyroid Nodule, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is an experimental study wherein groups of medical students and physicians of varying degrees of experience in head-and-neck ultrasound were asked to scan the same five patients each with a thyroid nodule. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Thyroid Nodule
What is being tested?
S-Detect for Thyroid
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteDenmark
Study dates
1 Sep 2023to 4 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Last year student
  • Doctor enrolled in introductory training as ENT physician.
  • Senior ENT registrar doctors
  • Doctor enrolled in ENT training.

Who cannot join

  • Experience with ultrasound beyond that which is taught at the University of Copenhagen
  • Junior ENT registrar doctors

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Rigshospitalet

    Copenhagen, 2100

Other trials in Denmark

About this study

This is an experimental study wherein groups of medical students and physicians of varying degrees of experience in head-and-neck ultrasound were asked to scan the same five patients each with a thyroid nodule.

The study participants did their own ultrasound assessment of the thyroid nodules, as well as using an AI-based ultrasound diagnostics system.

The researchers intended to study two primary outcomes: 1) how varying degrees of experience in ultrasound by the operator might affect the diagnostic performance of the AI-based system, and 2) how the AI-based system influenced the diagnostic performance of the ultrasound operator.

Read the detailed description

This is a prospective clinical study aiming to test how the experience of the ultrasound operator influences the performance of AI-based (artificial intelligence-based) diagnostics when analysing thyroid nodules on ultrasound scans. The investigators set up an experiment with five stations, each with a patient with a thyroid nodule and an ultrasound machine with the deep learning based system S-Detect for Thyroid installed. 20 study participants where recruited: 8 medical students of novice ultrasound skill, 3 junior ENT (ear-nose-throat) registrars of intermediate ultrasound skill, and 9 senior ENT registrars experienced in ultrasound. The participants scanned all the patients and recorded their analyses of the nodules using the EUTIRADS (European thyroid imagining reporting and data system) system in three different ways: a analysis of their own, S-Detect's analysis, and an analysis combining the two previous.

The hypothesis was that the AI system would perform equally well when between the participant groups. In addition, it was expected that the experienced participants would perform better than the students without AI help, and that the doctors would gain little from AI input, but that the students would have their performance improved by AI input.

Conditions
Thyroid Nodule
Being tested
S-Detect for Thyroid
Keywords
Ultrasound, AI, Thyroid cancer
Medical subject headings
Thyroid Nodule, Thyroid Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • S-Detect for ThyroidDiagnostic test

    Deep learning based program on Samsung ultrasound machines designed to do real-time semi-automated analysis of thyroid nodules. The ultrasound operator freezes a transverse image of the patient's thyroid nodule and activates S-Detect. The operator selects the nodule on the screen, and the program automatically draws a region of interest. Then S-Detect gives a dichotomous diagnosis of either "Possibly benign" and "Possibly malignant". In addition, it measures the nodule and characterises it with a lexicon based on EUTIRADS.

Study groups in NCT06306599
Study groupRoleWhat they receive
ExperimentExperimental20 participants ultrasound scan five patients with thyroid nodules, and assess these nodules themselves, then with the AI-program, and at last they give a combined assessment.
Receives: Diagnostic Test: S-Detect for Thyroid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of S-Detect diagnosis

    Number of correct thyroid nodule malignancy diagnoses out of total malignancy diagnoses by the AI-based ultrasound diagnostic system "S-Detect" on the five patients' thyroid nodules. Gold standard is cytology and histology of the nodules.

    Measured: 1 day (day of experiment)

Secondary outcomes (3)
  1. Accuracy of biopsy recommendation

    Number of correct biopsy recommendations on the five patients' thyroid nodules. Recommendation is derived from EUTIRADS analyses done by participants with and without AI assistance. Gold standard is biopsy recommendation derived from expert consensus EUTIRADS assessment of the nodules.

    Measured: 1 day (day of experiment)

  2. Nodule measurement

    Measurement of the five patients' thyroid nodules done by participants and S-Detect. Gold standard are measurements from expert consensus assessment analysis of the nodules.

    Measured: 1 day (day of experiment)

  3. OSAUS score

    Mean OSAUS (objective structured assessment of ultrasound skills) scores of participants as assessed from their ultrasound scans of the five patients. Assessment are independently by two head-and-neck ultrasound experts.

    Measured: 1 day (day of experiment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2024
  2. Study start1 Sep 2023
  3. Primary completion4 Nov 2023
  4. Study completion4 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
20 participants scan five patients over the course of fours hour and collect their diagnostics analyses on paper forms.
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06306599
Sponsor's protocol ID
Thyroid AI US operator exp
Status last verified
Nov 2024
First submitted
23 Feb 2024
Last updated
25 Nov 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing S-Detect for Thyroid in people with Thyroid Nodule, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of S-Detect diagnosis (time frame: 1 day (day of experiment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in